SLC5A6 Knockout HCT 116 Cell Line
Cat.No.:
EDC07824
Species:
Human
Cell Name:
HCT 116
Gene:
SLC5A6
Gene ID:
8884
Size:
1×10⁶cells
SLC5A6 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07824 |
|---|---|
| Product Name | SLC5A6 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene ID | |
| Gene | SLC5A6 |
| Gene Synonyms | COMNB|NERIB|SMVT|SMVTD|hSMVT |
| Summary |
Enables biotin transmembrane transporter activity; iodide transmembrane transporter activity; and pantothenate transmembrane transporter activity. Involved in iodide transmembrane transport; transport across blood-brain barrier; and vitamin transmembrane transport. Located in apical plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
|
| Digestion Time | 3 min |
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC5A6 function, SLC5A6 Knockout HCT 116 Cell Line or SLC5A6 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC5A6 (SMVT)'s role in intestinal biotin and pantothenate uptake or its emerging functions in colorectal cancer drug delivery research. The Knockout line is the standard tool for asking whether SMVT is required for intestinal vitamin transport in an epithelial cancer context. Overexpression is useful for transport activity studies and for biotin-conjugate drug delivery research.
For intestinal SMVT research, the EDITGENE Knockout in HCT 116 is particularly relevant — HCT 116 supports intestinal-relevant transport studies, and SMVT overexpression has been explored as a biotin-targeted drug delivery strategy in colorectal cancer. This product complements the parallel SLC5A6 Knockout in HEK293 (also available); HCT 116 is preferred for intestinal absorption biology and CRC drug development contexts. Rescue with wild-type or transport-deficient SMVT is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Intestinal biotin/pantothenate uptake: ³H-biotin uptake in the HCT 116 intestinal-relevant context.
• Biotin-conjugate drug delivery: testing efficiency of biotinylated drug uptake — relevant to SMVT-targeted colorectal cancer drug delivery strategies.
• Drug-vitamin interaction studies: assessment of competition between biotin and pantothenate substrates.
• Cancer phenotype assays: proliferation in vitamin-restricted conditions, given SMVT's role in cellular vitamin supply.
EDITGENE recommends this HCT 116-based model for intestinal absorption biology and SMVT-targeted colorectal cancer drug delivery research; the parallel SLC5A6 Knockout in HEK293 is preferred for biochemical mechanism studies.
Is this SLC5A6 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. SMVT rescue experiments in HCT 116 are particularly relevant for intestinal absorption research:
• Construct design: use a codon-modified SLC5A6 sequence with a small C-terminal tag (FLAG, HA). Membrane topology must be preserved.
• Polarized epithelial considerations: HCT 116 retains some epithelial polarity features — rescue can examine apical SMVT localization in epithelial-context cells.
• Drug delivery readouts: rescue with wild-type SMVT enables direct comparison of biotin-conjugate drug uptake versus native biotin transport.
• Functional readout: rescue should restore intestinal-relevant vitamin uptake activities.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation for intestinal-relevant SMVT studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download